Longitudinal trends in the prevalence of hyperuricaemia and chronic kidney disease in hypertensive and normotensive adults
- 19 May 2020
- journal article
- research article
- Published by Taylor & Francis in Blood Pressure
- Vol. 29 (5) , 308-318
Abstract
The purpose: To evaluate longitudinal trends in the prevalence of hyperuricaemia and chronic kidney disease (CKD) in Czech adults with and without arterial hypertension (HT). Materials and methods: Two independent cross-sectional surveys were performed in 2006–2009 and 2015–2018, each screening involving 1% population random sample of the general population of nine districts of the Czech Republic aged 25–64 years, stratified by age and gender. Hyperuricaemia was defined as serum uric acid ≥ 420 μmol/l in men, and ≥ 360 μmol/l in women. CKD was defined as estimated glomerular filtration rate < 60 ml/min/1.73 m2 and/or albumin/creatinine ratio ≥ 3 mg/mmol. Results: Final analyses included 3504 individuals examined in 2006–2009, and 2309 in 2015–2018. The overall prevalence of hyperuricaemia increased from 16.4% to 25.2% in men (p < 0.001), and from 7.6% to 10.9% in women (p < 0.001), whereas the overall prevalence of CKD declined from 6.8% to 3.6% in men (p = 0.001), and from 7.6% to 4.8% in women (p < 0.001). There was no interaction between HT and hyperuricaemia in either gender; the increase in hyperuricaemia prevalence was observed both in hypertensive and normotensive adults and was accompanied by the increased prevalence of abdominal obesity. Contrarily, there was an interaction between HT and CKD in both men (p < 0.001) and women (p = 0.011); the CKD prevalence declined only in hypertensive individuals, specifically in those using antihypertensive medication and was accompanied by the increased use of renin-angiotensin-aldosterone system (RAS) inhibitors and calcium channel blockers (CCBs). Conclusions: Over the period of 10 years, the overall prevalence of hyperuricaemia increased, while the prevalence of CKD decreased. An increase in the prevalence of hyperuricaemia was observed both in hypertensive and normotensive individuals and was accompanied by an increase in the prevalence of abdominal obesity. A decline in the prevalence of CKD was only observed in hypertensive individuals and was accompanied by the increased use of RAS inhibitors and CCBs.Keywords
This publication has 36 references indexed in Scilit:
- Epidemiology of gout and hyperuricaemia in Italy during the years 2005–2009: a nationwide population-based studyAnnals of the Rheumatic Diseases, 2013
- Prevalence of gout and hyperuricemia in the US general population: The National Health and Nutrition Examination Survey 2007-2008Arthritis & Rheumatism, 2011
- Longitudinal trends in cardiovascular mortality and blood pressure levels, prevalence, awareness, treatment, and control of hypertension in the Czech population from 1985 to 2007/2008Journal Of Hypertension, 2010
- Longitudinal trends in major cardiovascular risk factors in the Czech population between 1985 and 2007/8. Czech MONICA and Czech post-MONICAAtherosclerosis, 2010
- Prevalence of Chronic Kidney Disease in the United StatesJAMA, 2007
- International Comparison of the Relationship of Chronic Kidney Disease Prevalence and ESRD RiskJournal of the American Society of Nephrology, 2006
- The validity of screening based on spot morning urine samples to detect subjects with microalbuminuria in the general populationKidney International, 2005
- Subtle Acquired Renal Injury as a Mechanism of Salt-Sensitive HypertensionNew England Journal of Medicine, 2002
- Effects of Losartan on Renal and Cardiovascular Outcomes in Patients with Type 2 Diabetes and NephropathyNew England Journal of Medicine, 2001
- Effects of losartan and candesartan monotherapy and losartan/hydrochlorothiazide combination therapy in patients with mild to moderate hypertensionClinical Therapeutics, 2000